| Host: |
Rabbit |
| Applications: |
WB/ELISA |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. |
| Purification: |
Affinity purification |
| Concentration: |
Lot specific |
| Dilution Range: |
WB:1:500-1:2000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
| Gene Symbol: |
WNK2 |
| Gene ID: |
65268 |
| Uniprot ID: |
WNK2_HUMAN |
| Immunogen Region: |
61-160 aa |
| Specificity: |
Recombinant fusion protein containing a sequence corresponding to amino acids 61-160 of human WNK2 (NP_001269323.1). |
| Immunogen Sequence: |
EAPGPQPPQPLQRRVLLLCK TRRLIAERARGRPAAPAPAA LVAQPGAPGAPADAGPEPVG TQEPGPDPIAAAVETAPAPD GGPREEAAATVRKEDEGAAE |
| Tissue Specificity | Expressed in various cancer cell lines (at protein level). Predominantly expressed in heart, brain, skeletal muscle and colon. |
| Post Translational Modifications | Autophosphorylated. Autophosphorylation at Ser-352 and Ser-356 promotes its activity. |
| Function | Serine/threonine-protein kinase component of the WNK2-SPAK/OSR1 kinase cascade, which plays an important role in the regulation of electrolyte homeostasis, cell signaling, survival, and proliferation. The WNK2-SPAK/OSR1 kinase cascade is composed of WNK2, which mediates phosphorylation and activation of downstream kinases OXSR1/OSR1 and STK39/SPAK. Following activation, OXSR1/OSR1 and STK39/SPAK catalyze phosphorylation of ion cotransporters, regulating their activity. Acts as an activator and inhibitor of sodium-coupled chloride cotransporters and potassium-coupled chloride cotransporters respectively. Activates SLC12A2, SCNN1A, SCNN1B, SCNN1D and SGK1 and inhibits SLC12A5. Negatively regulates the EGF-induced activation of the ERK/MAPK-pathway and the downstream cell cycle progression. Affects MAPK3/MAPK1 activity by modulating the activity of MAP2K1 and this modulation depends on phosphorylation of MAP2K1 by PAK1. WNK2 acts by interfering with the activity of PAK1 by controlling the balance of the activity of upstream regulators of PAK1 activity, RHOA and RAC1, which display reciprocal activity. |
| Protein Name | Serine/Threonine-Protein Kinase Wnk2Antigen Ny-Co-43Protein Kinase Lysine-Deficient 2Protein Kinase With No Lysine 2Serologically Defined Colon Cancer Antigen 43 |
| Database Links | Reactome: R-HSA-2672351 |
| Cellular Localisation | CytoplasmCell Membrane |
| Alternative Antibody Names | Anti-Serine/Threonine-Protein Kinase Wnk2 antibodyAnti-Antigen Ny-Co-43 antibodyAnti-Protein Kinase Lysine-Deficient 2 antibodyAnti-Protein Kinase With No Lysine 2 antibodyAnti-Serologically Defined Colon Cancer Antigen 43 antibodyAnti-WNK2 antibodyAnti-KIAA1760 antibodyAnti-PRKWNK2 antibodyAnti-SDCCAG43 antibodyAnti-P antibodyAnti-OKcl.13 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
